Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000908834-22-000110
Filing Date
2022-07-14
Accepted
2022-07-14 15:55:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 INITIAL 13G 13g_beamthera.htm SC 13G 429128
  Complete submission text file 0000908834-22-000110.txt   430804
Mailing Address C/O FARALLON PARTNERS, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111
Business Address C/O FARALLON PARTNERS, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111 (415) 421-2132
Farallon Capital Partners, L.P. (Filed by) CIK: 0001175707 (see all company filings)

EIN.: 943106322 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Subject) CIK: 0001745999 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91369 | Film No.: 221083028
SIC: 2836 Biological Products, (No Diagnostic Substances)